Design Therapeutics Inc (DSGN)
3.26
-0.09
(-2.69%)
USD |
NASDAQ |
Jun 26, 11:01
Design Therapeutics Accounts Payable (Quarterly): 1.372M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.372M |
| December 31, 2023 | 1.94M |
| September 30, 2023 | 2.207M |
| June 30, 2023 | 1.922M |
| March 31, 2023 | 2.744M |
| December 31, 2022 | 3.025M |
| September 30, 2022 | 2.622M |
| Date | Value |
|---|---|
| June 30, 2022 | 2.071M |
| March 31, 2022 | 1.901M |
| December 31, 2021 | 1.62M |
| September 30, 2021 | 2.216M |
| June 30, 2021 | 1.585M |
| March 31, 2021 | 2.033M |
| December 31, 2020 | 1.399M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.372M
Minimum
Mar 2024
3.025M
Maximum
Dec 2022
2.047M
Average
1.986M
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen Inc | 387.00M |
| AbbVie Inc | -- |
| PTC Therapeutics Inc | 27.46M |
| Revance Therapeutics Inc | 5.276M |
| Context Therapeutics Inc | 2.045M |